陶瓷轴承在全美90天捆绑支付期内对所有患者是否更具成本效益
该研究基于美国Medicare 2010至2015年245077例65岁以上首次全髋关节置换术患者数据,分析陶瓷-聚乙烯(C-PE)和陶瓷-陶瓷(COC)轴承相比金属-聚乙烯(M-PE)轴承在90天捆绑支付期内的医院总成本差异。调整患者和临床因素及手术年份后,C-PE或COC轴承的90天平均医院成本与M-PE轴承相差在±1%以内(P < .001),非参数分析显示C-PE和COC的中位总医院成本比M-PE多296至353美元,成本差异随时间显著下降(P < .001)。结论认为患者和临床因素对住院全髋关节置换术总成本的影响远大于轴承选择,陶瓷轴承相对M-PE的成本效益阈值随时间变化且对Medicare人群越来越可实现。
要点
- 调整后C-PE或COC轴承的90天平均医院成本与M-PE相差在±1%以内(P < .001)。
- 非参数分析中C-PE和COC的中位总医院成本比M-PE多296至353美元。
- 陶瓷轴承与M-PE的成本差异随时间显著下降(P < .001)。
核心结论
- 患者和临床因素对住院全髋关节置换术总成本的影响远大于轴承选择,即使纳入出院后90天再入院成本也是如此。
- 研究结果表明陶瓷轴承相对M-PE的成本效益阈值随时间变化,对Medicare人群越来越可实现。
研究设计与样本
- 从美国Medicare 100%全国行政医院索赔数据库识别2010至2015年间接受首次全髋关节置换术的65岁以上老年Medicare患者共245077例。
- 使用成本-收费比计算至指数出院后90天的总住院成本,并分析医院支付。
- 采用参数和非参数模型评估C-PE和COC轴承相比M-PE轴承的总住院成本差异。
主要发现
- 调整患者和临床因素及手术年份后,C-PE或COC首次全髋关节置换术的90天平均医院成本与M-PE轴承相差在±1%以内(P < .001)。
- 非参数分析显示C-PE和COC的中位总医院成本比M-PE多296至353美元。
- 成本差异随时间显著下降(P < .001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We analyzed whether the total hospital cost in a 90-day bundled payment period for ceramic-on-polyethylene (C-PE) and ceramic-on-ceramic (COC) total hip arthroplasty (THA) bearings was changing over time, and whether the cost differential between ceramic bearings and metal-on-polyethylene (M-PE) bearings was approaching the previously published tipping point for cost-effectiveness of US$325. METHODS: A total of 245,077 elderly Medicare patients (65+) who underwent primary THA between 2010 and 2015 were identified from the United States Medicare 100% national administrative hospital claims database. The total inpatient cost, calculated up to 90 days after index discharge, was computed using cost-to-charge ratios, and hospital payment was analyzed. The differential total inpatient cost of C-PE and COC bearings, compared to metal-on-polyethylene (M-PE), was evaluated using parametric and nonparametric models. RESULTS: After adjustment for patient and clinical factors, and the year of surgery, the mean hospital cost up to 90 days for primary THA with C-PE or COC was within ±1% of the cost for primary THA with M-PE bearings (P < .001). From the nonparametric analysis, the median total hospital cost was US$296-US$353 more for C-PE and COC than M-PE. Cost differentials were found to decrease significantly over time (P < .001). CONCLUSION: Patient and clinical factors had a far greater impact on the total cost of inpatient THA surgery than bearing selection, even when including readmission costs up to 90 days after discharge. Our findings indicate that the cost-effectiveness thresholds for ceramic bearings relative to M-PE are changing over time and increasingly achievable for the Medicare population.
引用
- Kurtz SM, Lau E, Baykal D, et al. Are Ceramic Bearings Becoming Cost-Effective for All Patients Within a 90-Day Bundled Payment Period? J Arthroplasty. 2019. PMID: 30799268. doi:10.1016/j.arth.2019.01.074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。